UVSP Latest Report

Performance of this financial report

Pennsylvania Yuyi Bank (UVSP) recorded a total operating revenue of RMB76802000 as of December 31, 2024, up 7.56% from RMB71380000 in 2023. This growth reflects the bank's solid performance in revenue generation, mainly benefiting from business expansion and increased market demand.

Key data in the financial report

1. The operating revenue in 2024 was RMB76802000, up RMB5412000 from RMB71380000 in 2023, a 7.56% increase.

2. Insurance business revenue increased from RMB823000 to RMB1012000, up 23.08%.

3. Commission expenses increased from RMB23460000 to RMB25951000, up 10.59%.

4. EBIT increased from RMB88689000 to RMB95300000, indicating the company's effective cost control and revenue improvement.

5. Net profit increased from RMB16254000 to RMB18941000, up 16.56%, showing improved profitability.

Peer comparison

1. Industry-wide analysis: The improvement in the overall economic environment of the financial services industry and the rise in interest rates have driven revenue growth for banks, with many reporting similar revenue growth trends, indicating the recovery of market demand and increased credit demand from customers.

2. Peer evaluation analysis: UVSP's operating revenue growth of 7.56% is good among its peers, possibly indicating its enhanced competitiveness in the market.

Summary

UVSP's operating revenue growth is mainly driven by its active expansion in insurance business and other revenue sources. Although commission expenses have increased, the overall revenue growth rate is still higher than the growth rate of expenses, indicating that the company has maintained effective growth and profitability in the market.

Opportunities

1. Continue to strengthen the market promotion of separation membranes and water treatment equipment, further increasing sales.

2. Actively adopt new technologies, especially in the field of photovoltaic cell pieces, to enhance product competitiveness.

3. Expand market coverage in tier 3 and 4 cities and seek cooperation in fields such as traditional Chinese medicine, promoting the multi-sector application of products.

Risks

1. It may face risks from macroeconomic fluctuations, affecting overall operating revenue.

2. The growth of insurance business revenue may be unstable, and the competition situation needs to be paid attention to.

3. Intensified industry competition may put pressure on the company's market share.